What is Fulcrum Therapeutics Inc (FULC)?
Fulcrum Therapeutics Inc. is a biopharmaceutical company dedicated to discovering and developing novel therapies for genetically defined diseases. The company's research focuses on modulating gene expression to address underlying causes of rare and serious conditions. It employs a precision medicine approach, utilizing insights from genetics and molecular biology to identify therapeutic targets. The company's pipeline includes small molecules designed to regulate gene activity and restore normal cellular function. It operates within the biotechnology industry, engaging in research, development, and clinical evaluation of its drug candidates. The company collaborates with academic and industry partners to advance its programs.
Fulcrum Therapeutics Inc Stock Price Today: Live Overview
The price today is shaped by ongoing market activity in Fulcrum Therapeutics Inc, now priced at $6.92. The trading range today is between $6.69 and $7.07, with a daily change of +2.3739%.
FAQ: Fulcrum Therapeutics Inc (FULC)
What is the current price of FULC stock?
The current price is $6.92.
Does FULC pay dividends?
Fulcrum Therapeutics Inc does not pay dividends.
Does FULC have a formal corporate presence or regional headquarters in the UAE?
Fulcrum Therapeutics operates through partners in the UAE without a regional office or subsidiary.
What is FULC best known for?
The company is most famous for developing therapies for rare genetic diseases.
What assets are typically shown together with FULC?
Commonly shown alongside FULC: Telenor, Ambarella, Inc. - Ordinary Shar, Telecom Italia
Latest shares articles



